NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat

Yongzhong Wei, Adam T. Whaley-Connell, Kemin Chen, Javad Habibi, Grace M.E. Uptergrove, Suzanne E. Clark, Craig S. Stump, Carlos M. Ferrario, James R. Sowers

Research output: Contribution to journalArticle

87 Scopus citations

Abstract

Reduced insulin sensitivity is characteristic of various pathological conditions such as type 2 diabetes mellitus and hypertension. Angiotensin II, acting through its angiotensin type 1 receptor, inhibits the actions of insulin in the vasculature which may lead to deleterious effects such as vascular inflammation, remodeling, endothelial dysfunction, and insulin resistance. In contrast, insulin normally exerts vasodilatory, antiinflammatory, and prosurvival actions. To explore the impact of angiotensin II on insulin signaling, NADPH oxidase-derived reactive oxygen species formation, vascular inflammation, apoptosis, and remodeling, we used transgenic TG(mRen2)27 (Ren2) rats, which harbor the mouse renin transgene and exhibits elevated tissue angiotensin II levels. Compared with Sprague-Dawley controls, Ren2 aortas exhibited greater NADPH oxidase activity, reactive oxygen species levels, C-reactive protein, tumor necrosis factor-α expression, apoptosis, and wall thickness, which were significantly attenuated by in vivo treatment with angiotensin type 1 receptor blockade (valsartan) or the superoxide dismutase/catalase mimetic (tempol). There was substantially diminished Akt and endothelial NO synthase activation in Ren2 aortas in response to in vivo insulin stimulation, and this was significantly improved by in vivo treatment with valsartan or tempol. In vivo treatment with valsartan, but not tempol, significantly reduced blood pressure in Ren2 rats. Further, there was reduced insulin induced Akt activation and increased tumor necrosis factor-α levels in vascular smooth muscle cells from Ren2 and Sprague-Dawley rats treated with angiotensin II, abnormalities that were abrogated by angiotensin type 1 receptor blockade with valsartan or antioxidant N-acetylcysteine. Collectively, these data suggest that increased angiotensin type 1 receptor/NADPH oxidase activation/reactive oxygen species contribute to vascular insulin resistance, endothelial dysfunction, apoptosis, and inflammation.

Original languageEnglish (US)
Pages (from-to)384-391
Number of pages8
JournalHypertension
Volume50
Issue number2
DOIs
StatePublished - Aug 1 2007

Keywords

  • Apoptosis
  • Insulin resistance
  • NADPH oxidase
  • ROS
  • Ren2 rat
  • Vascular inflammation

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat'. Together they form a unique fingerprint.

  • Cite this

    Wei, Y., Whaley-Connell, A. T., Chen, K., Habibi, J., Uptergrove, G. M. E., Clark, S. E., Stump, C. S., Ferrario, C. M., & Sowers, J. R. (2007). NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat. Hypertension, 50(2), 384-391. https://doi.org/10.1161/HYPERTENSIONAHA.107.089284